沃华医药
(002107)
| 流通市值：37.71亿 | | | 总市值：38.21亿 |
| 流通股本：5.70亿 | | | 总股本：5.77亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 431,483,318.34 | 404,025,624.09 | 344,774,257.71 | 327,460,207.48 |
| 应收票据及应收账款 | 69,976,290.14 | 69,102,264.71 | 66,522,465.53 | 65,782,797.54 |
| 其中：应收票据 | 2,446,864.21 | 2,707,937.99 | 3,395,801.26 | 1,552,808.71 |
| 应收账款 | 67,529,425.93 | 66,394,326.72 | 63,126,664.27 | 64,229,988.83 |
| 应收款项融资 | 2,470,850.79 | 3,496,997.75 | 4,477,892.05 | 3,929,365.17 |
| 预付款项 | 2,983,407.61 | 3,839,211.85 | 2,908,012.71 | 2,205,487.95 |
| 其他应收款合计 | 1,683,658.87 | 1,815,635.33 | 11,793,033.61 | 15,669,601.19 |
| 存货 | 101,298,840.45 | 98,562,497.96 | 107,134,043.15 | 115,227,500.42 |
| 其他流动资产 | 4,760,440.04 | 4,918,796.93 | 5,508,698 | 6,578,522.76 |
| 流动资产合计 | 614,656,806.24 | 585,761,028.62 | 543,118,402.76 | 536,853,482.51 |
| 非流动资产: | | | | |
| 投资性房地产 | 17,294,061.36 | 17,474,749.71 | 17,655,438.06 | 17,836,126.41 |
| 固定资产 | 339,479,026.23 | 346,575,022.11 | 353,401,190.89 | 360,667,316.95 |
| 使用权资产 | 1,589,862.62 | 1,822,551.77 | 2,055,420.92 | - |
| 无形资产 | 34,938,625.66 | 35,244,721.39 | 35,564,098.09 | 35,883,474.79 |
| 商誉 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 |
| 递延所得税资产 | 377,525.82 | 381,857.21 | 1,034,582.72 | 623,148.26 |
| 其他非流动资产 | 10,000 | 10,000 | 392,700 | 416,126 |
| 非流动资产合计 | 426,197,766.22 | 434,017,566.72 | 442,612,095.21 | 447,934,856.94 |
| 资产总计 | 1,040,854,572.46 | 1,019,778,595.34 | 985,730,497.97 | 984,788,339.45 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 50,754,116.66 | 46,088,085.67 | 41,965,269.31 | 49,575,749.15 |
| 其中：应付票据 | - | - | 0 | 6,861,600.2 |
| 应付账款 | 50,754,116.66 | 46,088,085.67 | 41,965,269.31 | 42,714,148.95 |
| 合同负债 | 2,421,581.92 | 2,364,396.69 | 6,850,350.2 | 4,161,199.46 |
| 应付职工薪酬 | 7,520,734.01 | 7,301,744.32 | 9,262,176.41 | 6,549,867.06 |
| 应交税费 | 12,568,613.01 | 13,710,316.88 | 11,378,405.47 | 10,558,827.87 |
| 其他应付款合计 | 40,613,301.04 | 35,986,809.46 | 33,720,814.11 | 35,216,470.38 |
| 一年内到期的非流动负债 | 903,388.13 | 895,018.37 | 1,022,029.43 | - |
| 其他流动负债 | 147,529,059.32 | 152,675,135.81 | 138,090,788.41 | 149,187,680.17 |
| 流动负债合计 | 262,310,794.09 | 259,021,507.2 | 242,289,833.34 | 255,249,794.09 |
| 非流动负债: | | | | |
| 租赁负债 | 789,715.59 | 1,063,684.4 | 1,154,729.92 | - |
| 长期应付职工薪酬 | 121,788.49 | 167,031.76 | 209,968.36 | 233,407.87 |
| 预计负债 | - | - | 0 | - |
| 递延收益 | 13,499,465.83 | 14,232,481 | 14,965,496.17 | 15,698,511.34 |
| 递延所得税负债 | 3,940,969.81 | 4,167,510.92 | 4,176,295.75 | 4,291,798.3 |
| 非流动负债合计 | 18,351,939.72 | 19,630,708.08 | 20,506,490.2 | 20,223,717.51 |
| 负债合计 | 280,662,733.81 | 278,652,215.28 | 262,796,323.54 | 275,473,511.6 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 577,209,600 | 577,209,600 | 577,209,600 | 577,209,600 |
| 盈余公积 | 46,272,148.97 | 46,272,148.97 | 46,272,148.97 | 44,242,510.95 |
| 未分配利润 | 118,562,949.38 | 96,746,369.31 | 73,886,556.43 | 62,422,443.4 |
| 归属于母公司股东权益合计 | 742,044,698.35 | 720,228,118.28 | 697,368,305.4 | 683,874,554.35 |
| 少数股东权益 | 18,147,140.3 | 20,898,261.78 | 25,565,869.03 | 25,440,273.5 |
| 股东权益合计 | 760,191,838.65 | 741,126,380.06 | 722,934,174.43 | 709,314,827.85 |
| 负债和股东权益合计 | 1,040,854,572.46 | 1,019,778,595.34 | 985,730,497.97 | 984,788,339.45 |
| 公告日期 | 2025-07-22 | 2025-04-26 | 2025-04-26 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |